Yayınlar & Eserler

Yayın Ağı
Makaleler 12
Tümü (12)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (12)
Scopus (11)

1. Serum neopterin concentrations and tryptophan degradation pattern in patients with late stage larynx carcinoma

ENGİN A. B., GÜNAYDIN R. Ö., KESİKLİ S. A., Fuchs D., HOŞAL A. Ş.
PTERIDINES , cilt.28, sa.2, ss.91-95, 2017 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

2. Elevated Serum Beta-Trace Protein Levels are Associated With the Presence of Atrial Fibrillation in Hypertension Patients

Yalcin M. U., Gurses K. M., KOÇYİĞİT D., KESİKLİ S. A., Tokgozoglu L., GÜÇ D., et al.
JOURNAL OF CLINICAL HYPERTENSION , cilt.18, sa.5, ss.439-443, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

3. Cardiac Autoantibody Levels Predict Recurrence Following Cryoballoon-Based Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation Patients

YALÇIN M. U., Gurses K. M., KOÇYİĞİT D., KESİKLİ S. A., Dural M., EVRANOS B., et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY , cilt.26, sa.6, ss.615-621, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

4. Elevated M2-muscarinic and beta 1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation

Yalcin M. U., GÜRSES K. M., KOÇYİĞİT D., KESİKLİ S. A., Ates A. H., EVRANOS B., et al.
CLINICAL RESEARCH IN CARDIOLOGY , cilt.104, sa.3, ss.226-233, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

5. M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation

Gurses K. M., Yalcin M. U., Kocyigit D., Kesikli S. A., Canpolat U., YORGUN H., et al.
EUROPACE , cilt.17, sa.2, ss.239-246, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

6. Chemotherapeutic Agents in Cancer Treatment and Tryptophan Metabolism

KESİKLİ S. A., Guler N.
TRYPTOPHAN METABOLISM: IMPLICATIONS FOR BIOLOGICAL PROCESSES, HEALTH AND DISEASE , ss.291-333, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

7. Therapeutic Proteins in Tumors and Targeted Therapeutic Agents for Cancer Patients

KESİKLİ S. A., KILIÇKAP S.
PROTEIN AND PEPTIDE LETTERS , cilt.20, sa.12, ss.1345-1359, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

8. Dose-dense effect: other contributors

KESİKLİ S. A., YÜCE D., KILIÇKAP S.
LANCET ONCOLOGY , cilt.14, sa.12, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

9. Prognosis of Colorectal Cancer With Peritoneal Carcinomatosis: Is a New Staging Necessary?

KESİKLİ S. A., EREN M. F., AKGÜL BABACAN N., KILIÇKAP S.
JOURNAL OF CLINICAL ONCOLOGY , cilt.30, sa.18, ss.2287-2288, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

10. Insulin Therapy and Cancer-Specific Mortality in Patients With Colorectal Cancer and Diabetes

KESİKLİ S. A., ÜNLÜTÜRK U., KILIÇKAP S.
JOURNAL OF CLINICAL ONCOLOGY , cilt.30, sa.14, ss.1729-1730, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. Identification of the peripheral blood levels of interleukin-12, interleukin-10, and transforming growth factor-beta in patients with laryngeal squamous cell carcinoma

GÜNAYDIN R. Ö., KESİKLİ S. A., KANSU E., HOŞAL A. Ş.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.34, sa.3, ss.393-397, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

12. Chemotherapy-Induced Spontaneous Orgasms in a Patient with Breast Cancer

KILIÇKAP S., KESİKLİ S. A., ERDİŞ E., YÜCEL B.
ANNALS OF PHARMACOTHERAPY , cilt.46, sa.1, ss.144-145, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Metrikler

Yayın

12

Yayın (WoS)

12

Yayın (Scopus)

11

Atıf (WoS)

78

H-İndeks (WoS)

4

Atıf (Scopus)

27

H-İndeks (Scopus)

1

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları